The pro-inflammatory cytokines, such as IL-12, IL-18, and IL-15, have been used to arm CAR-T cells (the fourth-generation CAR-T cells) to enhance tumor-killing capacity (11, 13, 14). Here, IL18 is linked to neoplasm.